These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3829376)

  • 21. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
    Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
    Wada N; Ishii S; Ikeda T; Enomoto K; Kitajima M
    Anticancer Res; 1999; 19(5C):4515-21. PubMed ID: 10650803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
    Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
    Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
    Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.
    Fagerlund KM; Janckila AJ; Ylipahkala H; Tiitinen SL; Nenonen A; Cheng S; Uusi-Rasi K; Yam LT; Väänänen HK; Halleen JM
    Clin Lab; 2008; 54(9-10):347-54. PubMed ID: 19097492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
    Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
    Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK
    Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
    Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
    Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.
    Nishizawa Y; Inaba M; Ishii M; Yamashita H; Miki T; Goto H; Yamada S; Chaki O; Kurasawa K; Mochizuki Y
    J Bone Miner Metab; 2008; 26(3):265-70. PubMed ID: 18470668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)].
    Mochizuki Y
    Clin Calcium; 2006 Jun; 16(6):948-55. PubMed ID: 16751690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
    Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
    J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ; Lederer ED; Price BA; Yam LT
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
    Tang SJ; Meikle MC; MacLaine JK; Wong RW; Rabie BM
    Eur J Orthod; 2013 Apr; 35(2):169-74. PubMed ID: 22467569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
    Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U
    Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.